+91 780-304-0404

Artificial Pancreas Device System Market

Global Artificial Pancreas Device System Market Size, Share & Trends Analysis Report by Type (Threshold Suspended Device System, Insulin-Only System, and Bi-Hormonal Control System) and Forecast 2019-2025
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2020005 | Category : Medical Devices | Delivery Format: /

The global artificial pancreas device system market is estimated to grow at an impressive growth rate of 55% during the forecast period. The artificial pancreas device system consists of two types of devices for diabetes monitoring; namely, continuous glucose monitoring (CGM) system and insulin infusion pump. As of 2019, the artificial pancreas device system has not been commercialized and is still in the development phase. 

Diabetes has been a major epidemic across the globe. The adult diabetic population was 425 million in 2018 with the prevalence rate reaching 8.5% as per the World Health Organization (WHO). Over 1.6 million mortality occurred due to diabetes in 2018 across the globe. The increasing prevalence of diabetes and its burden coupled with the rising need for advanced and innovative diabetic care devices is acting as a driving factor for the growth of the market in the near future. Moreover, increasing awareness among the population towards diabetes and the growing focus of organizations towards the efficacy and R&D of artificial pancreas device systems across the globe is augmenting the market growth. 

Segmental Outlook  

The global artificial pancreas device system market is segmented on the basis of type and region. On the basis of type, the market is sub-segmented into a threshold suspended device system, insulin-only system, and bi-hormonal control system. The threshold suspended device system serves as a potential back-up when a patient is unable to respond to low blood sugar (hypoglycemia) event. Owing to this, the threshold suspended device system segment is poised to hold significant potential during the forecast period.

Global Artificial Pancreas Device System Market Share by Type, 2018 (%)

Global Artificial Pancreas Device System Market Share by Type

Regional Outlook 

Geographically, the study of the global artificial pancreas device system market covers the analysis of four major regions including North America (the US and Canada), Europe (Germany, UK, Italy, France, Italy, Spain, and Rest of Europe), and Rest of the World (RoW). Asia-Pacific is estimated to be the potential market for the artificial pancreas device system during the forecast period. The rising geriatric population that is susceptible to diabetes disease would augment the demand for artificial pancreas device system in the region. 

Moreover, government support along with the growing awareness regarding disease diagnosis and treatment will further augment the regional business growth during the forecast period. The increasing prevalence of diabetes is accelerating the global interest within the innovative care models that deploy approaches such as community-based care coupled with information technology to enhance the prevention of diseases, diagnosis, and treatment. According to the International Disease Foundation, around 73 million people in India are suffering from diabetes. With the increase in Indian diabetic population, government institutions and pharmaceutical companies are concentrating majorly on developing innovative products. The integration of the healthcare sector and information technology has led to the development of innovative products.

Global Artificial Pancreas Device System Market Growth, by Region 2019-2025
Global Artificial Pancreas Device System Market Share by Region

North America Would Lead the Global Artificial Pancreas Device System Market Over the Forecast Period

The supportive government policies and the significant prevalence of diabetes in the region coupled with the ongoing R&D on the development of artificial pancreas device system make North America a major region in the artificial pancreas device system industry with the US being the major contributor. Moreover, the convergence of the medical industry in economies such as the US and Canada is further enabling researchers to pace-up the focus on the R&D of such advanced devices. According to the Centers for Disease Control and Prevention (CDC), 30.3 million people in the US had diabetes in 2017; among them, 23.1 million people were diagnosed, and 7.2 million patients remained undiagnosed. Thus, a high prevalence of diabetes and a high diagnosis rate through easy accessibility of technologically advanced devices are further fueling the regional growth of the market. 

Market Players Outlook

Key players operating in the global artificial pancreas device system market include Medtronic PLC, Johnson & Johnson Services Inc., Insulet Corp., Pancreum Inc., Tandem Diabetes Care Inc., and others. In order to remain competitive in the market, these market players adopt various strategies such as mergers and acquisitions, product offering expansion, geographical expansion, partnerships and collaborations, and others. Players operating in the market are also focusing on the market opportunities to capture the market share. 

Medtronic PLC has a significant contribution to the development of the artificial pancreas device system. The company focuses on the development of continuous glucose monitoring systems and insulin pumps. It has vast resources in terms of funding, human resource, and technical expertise to develop the artificial pancreas device system. In 2013, the company had total diabetic care product revenue of $1.6 billion. Integrated devices, insulin pumps, and CGMS were the primary contributors to it. 

Medtronic was the first company to launch an integrated system named “Veo” which was the first device to be approved in the European market in 2009. Minimed 530G along with Enlite sensor is touted as the first-generation artificial pancreas. However, these devices were not capable to suspend the insulin into the body automatically. In 2016, the FDA approved the first artificial pancreas developed by Medtronic. It is a technology that enables diabetic patients to automatically control their blood glucose levels by offering the substitute endocrine functionality of healthy pancreas. 

Recent Developments

  • In February 2019, the US FDA announced the approval of Tandem Diabetes Care’s t: slim X2 pumps. These pumps can make a reliable and secure communication with digitally connected devices such as insulin dosing software, to receive, execute, and confirm command from these devices. 
  • In 2018, Dexcom acquired TypeZero Technologies, a company that has a system designed to manage and regulate insulin delivery from insulin pumps. With the acquisition, Dexcom aims to be one of the major players in the development of artificial pancreas technology. 
The Report Covers

  • Market value data analysis of 2018 and forecast to 2025.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global artificial pancreas device system market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Geography

2. Market Overview and Insights

2.1. Scope of the Report 

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. Medtronic PLC

3.3.1.1. Overview

3.3.1.2. Financial Analysis

3.3.1.3. SWOT Analysis

3.3.1.4. Recent Developments

3.3.2. Johnson & Johnson Services Inc.

3.3.2.1. Overview

3.3.2.2. Financial Analysis

3.3.2.3. SWOT Analysis

3.3.2.4. Recent Developments

3.3.3. Insulet Corp.

3.3.3.1. Overview

3.3.3.2. SWOT Analysis

3.3.3.3. Recent Developments

3.3.4. Pancreum, Inc.

3.3.4.1. Overview

3.3.4.2. SWOT Analysis

3.3.4.3. Recent Developments

3.3.5. Tandem Diabetes Care, Inc.

3.3.5.1. Overview

3.3.5.2. SWOT Analysis

3.3.5.3. Recent Developments

4. Market Determinants

4.1. Motivators

4.2. Restraints

4.3. Opportunities

5. Market Segmentation

5.1. Global Artificial Pancreas Device System Market by Type

5.1.1. Threshold Suspended Device System

5.1.2. Insulin-Only System

5.1.3. Bi-Hormonal Control System 

6. Regional Analysis

6.1. North America

6.1.1. United States

6.1.2. Canada

6.2. Europe

6.2.1. UK

6.2.2. Germany

6.2.3. Italy

6.2.4. Spain

6.2.5. France

6.2.6. Rest of Europe

6.3. Asia-Pacific

6.3.1. China

6.3.2. Japan

6.3.3. India

6.3.4. Rest of Asia-Pacific

6.4. Rest of the World

7. Company Profiles

7.1. Admetsys Corp.

7.2. Beta Bionics

7.3. Beta-O2 Technologies Ltd.

7.4. Bigfoot Biomedical Inc.

7.5. Companion Medical Inc.

7.6. Defymed SAS

7.7. Dexcom Inc. 

7.8. Eli Lilly and Co.

7.9. Inreda Diabetic BV

7.10. Insulet Corp.

7.11. Johnson & Johnson Services Inc.

7.12. Medtronic PLC

7.13. Pancreum, Inc.

7.14. Tandem Diabetes Care, Inc.

  1. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  2. GLOBAL THRESHOLD SUSPENDED ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  3. GLOBAL INSULIN-ONLY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  4. GLOBAL BI-HORMONAL CONTROL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  5. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  6. NORTH AMERICAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  7. NORTH AMERICAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  8. EUROPEAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  9. EUROPEAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  10. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  11. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  12. REST OF THE WORLD ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  1. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SHARE BY TYPE, 2018 VS 2025 (%)
  2. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  3. US ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  4. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  5. UK ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  6. FRANCE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  7. GERMANY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  8. ITALY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  9. SPAIN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  10. ROE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  11. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  12. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  13. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  14. REST OF ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
  15. REST OF THE WORLD ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2025 ($ MILLION)
Choose License Type
    On Discount

100%
Secured Payment

Why buy from us?
  • Covers more than 15 major industries, which are further segmented into 90+ sectors
  • 65% of our clients are loyal customers
  • 120+ countries are covered in analysis
  • currently servicing 1000+ customers globally
  • 100+ paid data sources mined to research
  • Our expert team will assist you with all research need and customization
  • Our expert research analyst will resolve your every query before and after purchasing the report
Related Reports